Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine with or without Oxaliplatin in Pancreatic Cancer
NCT00058149Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Mar 2003
- Primary completion
- Jul 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 3 trial of oxaliplatin, gemcitabine in pancreatic cancer (PC), sponsored by Eastern Cooperative Oncology Group. Started Mar 2003; status: completed.
02
Drugs
oxaliplatingemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00058149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058149.